agilon health, inc. - Common stock, par value $0.01 (AGL)

Historical Holders from Q2 2021 to Q3 2025

Symbol
AGL on NYSE
CUSIP
00857U107
Type / Class
Equity / Common stock, par value $0.01
Shares outstanding
415M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
382M
Holdings value
$393M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
187
Number of buys
83
Number of sells
-105
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of agilon health, inc. - Common stock, par value $0.01 (AGL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 12.2% $193M 50.2M Morgan Stanley Mar 31, 2025
North Peak Capital Management, LLC 9.5% +86% $40.6M $18.4M 39.4M +83% North Peak Capital Management, LLC Sep 30, 2025
VANGUARD GROUP INC 5.86% $25M 24.3M The Vanguard Group Sep 30, 2025
FMR LLC 3.7% -63.3% $15.8M -$24.1M 15.4M -60.3% FMR LLC Sep 30, 2025
WELLINGTON MANAGEMENT GROUP LLP 3.6% -47.1% $57.5M -$51.4M 15M -47.2% Wellington Management Group LLP Mar 31, 2025
Capital World Investors 2.6% -76.4% $9.33M -$29.9M 10.9M -76.2% Capital World Investors Aug 29, 2025
Capital International Investors 2.4% -60% $22.1M -$27.7M 9.89M -55.7% Capital International Investors Jun 30, 2025

Institutional Holders of agilon health, inc. - Common stock, par value $0.01 (AGL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 382M $393M -$40.9M $1.03 187
2025 Q2 399M $919M -$3M $2.30 203
2025 Q1 400M $1.73B -$76.6M $4.33 197
2024 Q4 416M $791M -$38.6M $1.90 183
2024 Q3 428M $1.68B -$125M $3.93 209
2024 Q2 456M $2.98B +$91.1M $6.54 205
2024 Q1 442M $2.7B -$148M $6.10 199
2023 Q4 448M $5.63B -$50.7M $12.55 197
2023 Q3 450M $8B +$142M $17.76 189
2023 Q2 442M $7.66B -$98.8M $17.34 191
2023 Q1 447M $10.6B +$381M $23.75 203
2022 Q4 431M $6.97B +$109M $16.14 169
2022 Q3 423M $9.91B +$177M $23.42 172
2022 Q2 413M $9.02B +$291M $21.83 145
2022 Q1 400M $10.1B +$206M $25.35 118
2021 Q4 391M $10.5B +$1.56B $27.00 126
2021 Q3 332M $8.68B +$10.6M $26.21 102
2021 Q2 331M $13.2B +$13.2B $40.57 94